Genotype–phenotype studies of VCP‐associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia

Valosin containing protein (VCP) disease associated with inclusion body myopathy, Paget disease of the bone and frontotemporal dementia is a progressive autosomal dominant disorder caused by mutations in Valosin containing protein gene. To establish genotype–phenotype correlations we analyzed clinical and biochemical markers from a database of 190 members in 27 families harboring 10 missense mutations. Individuals were grouped into three categories: symptomatic, presymptomatic carriers and noncarriers. The symptomatic families were further divided into ten groups based on their VCP mutations. There was marked intra and inter‐familial variation; and significant genotype–phenotype correlations were difficult to establish because of small numbers. Nevertheless when comparing the two most common mutations, R155C mutation was found to be more severe, with an earlier onset of myopathy and Paget (p = 0.03). Survival analysis of all subjects revealed an average life span after diagnosis of myopathy and Paget of 18 and 19 years respectively, and after dementia only 6 years. R155C had a reduced survival compared to the R155H mutation (p = 0.03).We identified amyotrophic lateral sclerosis (ALS) was diagnosed in 13 individuals (8.9%) and Parkinson's disease in five individuals (3%); however, there was no genotypic correlation. This study represents the largest dataset of patients with VCP disease and expands our understanding of the natural history and provides genotype–phenotype correlations in this unique disease.

[1]  Sonja W. Scholz,et al.  Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.

[2]  I. Nonaka,et al.  Characterization of the Asian myopathy patients with VCP mutations , 2012, European journal of neurology.

[3]  J. Tehranzadeh,et al.  Radiological features of Paget disease of bone associated with VCP myopathy , 2012, Skeletal Radiology.

[4]  P. Freemont,et al.  The Role of the N-Domain in the ATPase Activity of the Mammalian AAA ATPase p97/VCP , 2012, The Journal of Biological Chemistry.

[5]  N. Ertekin-Taner,et al.  Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS , 2011, Neurology.

[6]  Charles D. Smith,et al.  The Multiple Faces of Valosin-Containing Protein-Associated Diseases: Inclusion Body Myopathy with Paget’s Disease of Bone, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis , 2011, Journal of Molecular Neuroscience.

[7]  D. Burke,et al.  Axonal hyperpolarization in inclusion‐body myopathy, paget disease of the bone, and frontotemporal dementia (IBMPFD) , 2011, Muscle & nerve.

[8]  W. Seeley,et al.  Inclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean family. , 2011, Archives of neurology.

[9]  M. Passos-Bueno,et al.  A Brazilian family with hereditary inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. , 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[10]  M. Rossor,et al.  A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes , 2011, Journal of Neurology.

[11]  D. Xia,et al.  A Novel ATP-Dependent Conformation in P97 N-D1 Fragment Revealed by Crystal Structures of Disease Related Mutants , 2011 .

[12]  Patrizia Sola,et al.  Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.

[13]  L. Esser,et al.  A novel ATP‐dependent conformation in p97 N–D1 fragment revealed by crystal structures of disease‐related mutants , 2010, The EMBO journal.

[14]  F. Mastaglia,et al.  Two Australian families with inclusion-body myopathy, Paget’s disease of bone and frontotemporal dementia: Novel clinical and genetic findings , 2010, Neuromuscular Disorders.

[15]  Charles D. Smith,et al.  Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts , 2009, Neuromuscular Disorders.

[16]  S. Engelborghs,et al.  Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His , 2009, Neurology.

[17]  N. Bresolin,et al.  Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation , 2009, Neurobiology of Aging.

[18]  K. Claeys,et al.  Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget’s disease of bone and frontotemporal dementia , 2009, Neuromuscular Disorders.

[19]  C. Smart,et al.  Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[20]  A. Djamshidian,et al.  A novel mutation in the VCP gene (G157R) in a german family with inclusion‐body myopathy with paget disease of bone and frontotemporal dementia , 2009, Muscle & nerve.

[21]  V. Kimonis,et al.  VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. , 2008, Biochimica et biophysica acta.

[22]  S. Ralston Pathogenesis of Paget's disease of bone. , 2008, Bone.

[23]  A. Pestronk,et al.  TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[24]  P. Delmas,et al.  Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis , 2008, Osteoporosis International.

[25]  Charles D. Smith,et al.  Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia , 2008, American journal of medical genetics. Part A.

[26]  S. DeKosky,et al.  Frontotemporal dementia associated with a Valosin‐Containing Protein mutation: report of three families , 2008 .

[27]  A. Broccolini,et al.  An Italian family with inclusion‐body myopathy and frontotemporal dementia due to mutation in the VCP gene , 2008, Muscle & nerve.

[28]  M. Hamshere,et al.  Identification of a Novel Valosin-Containing Protein Polymorphism in Late-Onset Alzheimer’s Disease , 2007, Neurodegenerative Diseases.

[29]  J. Morris,et al.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.

[30]  N. Cairns,et al.  TDP‐43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations , 2007, Journal of neuropathology and experimental neurology.

[31]  C. Duyckaerts,et al.  Valosin-containing protein gene mutations , 2006, Neurology.

[32]  Charles D. Smith,et al.  Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations , 2006, Journal of neuropathology and experimental neurology.

[33]  F. Zimprich,et al.  Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene , 2005, Neurology.

[34]  K. Fliessbach,et al.  Mutant valosin‐containing protein causes a novel type of frontotemporal dementia , 2005, Annals of neurology.

[35]  A. Pestronk,et al.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein , 2004, Nature Genetics.

[36]  A. Pestronk,et al.  Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes , 2003, Neuromuscular Disorders.

[37]  Mark A. Levenstien,et al.  Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. , 2001, Molecular genetics and metabolism.

[38]  Chou-Chi H. Li,et al.  Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin–proteasome degradation , 2001, Nature Cell Biology.

[39]  A. Wilkinson,et al.  AAA+ superfamily ATPases: common structure–diverse function , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[40]  S. Leal,et al.  Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone , 2000, Genetics in Medicine.

[41]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[42]  J. Bronstein,et al.  Valosin-containing protein mutation and Parkinson's disease. , 2012, Parkinsonism & related disorders.

[43]  최영철 Characterization of the Asian myopathy patients with VCP mutations. , 2012 .

[44]  Charles D. Smith,et al.  APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD) , 2007, Genetics in Medicine.

[45]  G. Roodman,et al.  Pathogenesis of Paget’s disease of bone , 2004 .

[46]  F. Freemon,et al.  A new familial disorder of combined lower motor neuron degeneration and skeletal disorganization. , 1982, Transactions of the Association of American Physicians.

[47]  Tucker Ws,et al.  A new familial disorder of combined lower motor neuron degeneration and skeletal disorganization. , 1982 .